The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Primary Hepatocytes Market Research Report 2025

Global Human Primary Hepatocytes Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1896209

No of Pages : 99

Ask Your Query
Synopsis
The global Human Primary Hepatocytes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Human primary hepatocytes have the following advantages: they are consistent with the in vivo environment, the levels of enzymes and cofactors are normal physiological concentrations, and drug metabolism and toxicity can be studied close to physiological conditions. It better retains and maintains the complete shape of liver cells and the metabolic activity of liver cells in vitro, truly reflecting the metabolic situation in the body.
This report aims to provide a comprehensive presentation of the global market for Human Primary Hepatocytes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Primary Hepatocytes.
Report Scope
The Human Primary Hepatocytes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Primary Hepatocytes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Primary Hepatocytes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
BioIVT
ScienCell Research Laboratories, Inc.
Creative Bioarray
BPS Bioscience, Inc.
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Segment by Type
Hepatocyte
Cytoplasmic Cells
Hepatic Stellate Cells
Bile Duct Epithelial Cells
Islet Cells
Segment by Application
Life Science Research Company
Research Institute
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Primary Hepatocytes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Primary Hepatocytes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hepatocyte
1.2.3 Cytoplasmic Cells
1.2.4 Hepatic Stellate Cells
1.2.5 Bile Duct Epithelial Cells
1.2.6 Islet Cells
1.3 Market by Application
1.3.1 Global Human Primary Hepatocytes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Life Science Research Company
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Primary Hepatocytes Market Perspective (2019-2030)
2.2 Human Primary Hepatocytes Growth Trends by Region
2.2.1 Global Human Primary Hepatocytes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Primary Hepatocytes Historic Market Size by Region (2019-2024)
2.2.3 Human Primary Hepatocytes Forecasted Market Size by Region (2025-2030)
2.3 Human Primary Hepatocytes Market Dynamics
2.3.1 Human Primary Hepatocytes Industry Trends
2.3.2 Human Primary Hepatocytes Market Drivers
2.3.3 Human Primary Hepatocytes Market Challenges
2.3.4 Human Primary Hepatocytes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Primary Hepatocytes Players by Revenue
3.1.1 Global Top Human Primary Hepatocytes Players by Revenue (2019-2024)
3.1.2 Global Human Primary Hepatocytes Revenue Market Share by Players (2019-2024)
3.2 Global Human Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Primary Hepatocytes Revenue
3.4 Global Human Primary Hepatocytes Market Concentration Ratio
3.4.1 Global Human Primary Hepatocytes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Primary Hepatocytes Revenue in 2023
3.5 Human Primary Hepatocytes Key Players Head office and Area Served
3.6 Key Players Human Primary Hepatocytes Product Solution and Service
3.7 Date of Enter into Human Primary Hepatocytes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Primary Hepatocytes Breakdown Data by Type
4.1 Global Human Primary Hepatocytes Historic Market Size by Type (2019-2024)
4.2 Global Human Primary Hepatocytes Forecasted Market Size by Type (2025-2030)
5 Human Primary Hepatocytes Breakdown Data by Application
5.1 Global Human Primary Hepatocytes Historic Market Size by Application (2019-2024)
5.2 Global Human Primary Hepatocytes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Primary Hepatocytes Market Size (2019-2030)
6.2 North America Human Primary Hepatocytes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Primary Hepatocytes Market Size by Country (2019-2024)
6.4 North America Human Primary Hepatocytes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Primary Hepatocytes Market Size (2019-2030)
7.2 Europe Human Primary Hepatocytes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Primary Hepatocytes Market Size by Country (2019-2024)
7.4 Europe Human Primary Hepatocytes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Primary Hepatocytes Market Size (2019-2030)
8.2 Asia-Pacific Human Primary Hepatocytes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Primary Hepatocytes Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Primary Hepatocytes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Primary Hepatocytes Market Size (2019-2030)
9.2 Latin America Human Primary Hepatocytes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Primary Hepatocytes Market Size by Country (2019-2024)
9.4 Latin America Human Primary Hepatocytes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Primary Hepatocytes Market Size (2019-2030)
10.2 Middle East & Africa Human Primary Hepatocytes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Primary Hepatocytes Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Primary Hepatocytes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Detail
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Human Primary Hepatocytes Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Human Primary Hepatocytes Introduction
11.2.4 Merck KGaA Revenue in Human Primary Hepatocytes Business (2019-2024)
11.2.5 Merck KGaA Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Human Primary Hepatocytes Introduction
11.3.4 Lonza Revenue in Human Primary Hepatocytes Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Cell Biologics, Inc.
11.4.1 Cell Biologics, Inc. Company Detail
11.4.2 Cell Biologics, Inc. Business Overview
11.4.3 Cell Biologics, Inc. Human Primary Hepatocytes Introduction
11.4.4 Cell Biologics, Inc. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.4.5 Cell Biologics, Inc. Recent Development
11.5 PromoCell GmbH
11.5.1 PromoCell GmbH Company Detail
11.5.2 PromoCell GmbH Business Overview
11.5.3 PromoCell GmbH Human Primary Hepatocytes Introduction
11.5.4 PromoCell GmbH Revenue in Human Primary Hepatocytes Business (2019-2024)
11.5.5 PromoCell GmbH Recent Development
11.6 HemaCare Corporation
11.6.1 HemaCare Corporation Company Detail
11.6.2 HemaCare Corporation Business Overview
11.6.3 HemaCare Corporation Human Primary Hepatocytes Introduction
11.6.4 HemaCare Corporation Revenue in Human Primary Hepatocytes Business (2019-2024)
11.6.5 HemaCare Corporation Recent Development
11.7 ZenBio, Inc.
11.7.1 ZenBio, Inc. Company Detail
11.7.2 ZenBio, Inc. Business Overview
11.7.3 ZenBio, Inc. Human Primary Hepatocytes Introduction
11.7.4 ZenBio, Inc. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.7.5 ZenBio, Inc. Recent Development
11.8 STEMCELL Technologies, Inc.
11.8.1 STEMCELL Technologies, Inc. Company Detail
11.8.2 STEMCELL Technologies, Inc. Business Overview
11.8.3 STEMCELL Technologies, Inc. Human Primary Hepatocytes Introduction
11.8.4 STEMCELL Technologies, Inc. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.8.5 STEMCELL Technologies, Inc. Recent Development
11.9 Corning Incorporated
11.9.1 Corning Incorporated Company Detail
11.9.2 Corning Incorporated Business Overview
11.9.3 Corning Incorporated Human Primary Hepatocytes Introduction
11.9.4 Corning Incorporated Revenue in Human Primary Hepatocytes Business (2019-2024)
11.9.5 Corning Incorporated Recent Development
11.10 Axol Bioscience Ltd.
11.10.1 Axol Bioscience Ltd. Company Detail
11.10.2 Axol Bioscience Ltd. Business Overview
11.10.3 Axol Bioscience Ltd. Human Primary Hepatocytes Introduction
11.10.4 Axol Bioscience Ltd. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.10.5 Axol Bioscience Ltd. Recent Development
11.11 iXCells Biotechnologies
11.11.1 iXCells Biotechnologies Company Detail
11.11.2 iXCells Biotechnologies Business Overview
11.11.3 iXCells Biotechnologies Human Primary Hepatocytes Introduction
11.11.4 iXCells Biotechnologies Revenue in Human Primary Hepatocytes Business (2019-2024)
11.11.5 iXCells Biotechnologies Recent Development
11.12 Neuromics
11.12.1 Neuromics Company Detail
11.12.2 Neuromics Business Overview
11.12.3 Neuromics Human Primary Hepatocytes Introduction
11.12.4 Neuromics Revenue in Human Primary Hepatocytes Business (2019-2024)
11.12.5 Neuromics Recent Development
11.13 BioIVT
11.13.1 BioIVT Company Detail
11.13.2 BioIVT Business Overview
11.13.3 BioIVT Human Primary Hepatocytes Introduction
11.13.4 BioIVT Revenue in Human Primary Hepatocytes Business (2019-2024)
11.13.5 BioIVT Recent Development
11.14 ScienCell Research Laboratories, Inc.
11.14.1 ScienCell Research Laboratories, Inc. Company Detail
11.14.2 ScienCell Research Laboratories, Inc. Business Overview
11.14.3 ScienCell Research Laboratories, Inc. Human Primary Hepatocytes Introduction
11.14.4 ScienCell Research Laboratories, Inc. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.14.5 ScienCell Research Laboratories, Inc. Recent Development
11.15 Creative Bioarray
11.15.1 Creative Bioarray Company Detail
11.15.2 Creative Bioarray Business Overview
11.15.3 Creative Bioarray Human Primary Hepatocytes Introduction
11.15.4 Creative Bioarray Revenue in Human Primary Hepatocytes Business (2019-2024)
11.15.5 Creative Bioarray Recent Development
11.16 BPS Bioscience, Inc.
11.16.1 BPS Bioscience, Inc. Company Detail
11.16.2 BPS Bioscience, Inc. Business Overview
11.16.3 BPS Bioscience, Inc. Human Primary Hepatocytes Introduction
11.16.4 BPS Bioscience, Inc. Revenue in Human Primary Hepatocytes Business (2019-2024)
11.16.5 BPS Bioscience, Inc. Recent Development
11.17 AcceGen
11.17.1 AcceGen Company Detail
11.17.2 AcceGen Business Overview
11.17.3 AcceGen Human Primary Hepatocytes Introduction
11.17.4 AcceGen Revenue in Human Primary Hepatocytes Business (2019-2024)
11.17.5 AcceGen Recent Development
11.18 Sekisui XenoTech, LLC
11.18.1 Sekisui XenoTech, LLC Company Detail
11.18.2 Sekisui XenoTech, LLC Business Overview
11.18.3 Sekisui XenoTech, LLC Human Primary Hepatocytes Introduction
11.18.4 Sekisui XenoTech, LLC Revenue in Human Primary Hepatocytes Business (2019-2024)
11.18.5 Sekisui XenoTech, LLC Recent Development
11.19 Biopredic International
11.19.1 Biopredic International Company Detail
11.19.2 Biopredic International Business Overview
11.19.3 Biopredic International Human Primary Hepatocytes Introduction
11.19.4 Biopredic International Revenue in Human Primary Hepatocytes Business (2019-2024)
11.19.5 Biopredic International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock